CA Patent

CA2987895A1 — Pharmaceutical compositions of dimethyl fumarate

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2016-12-08 · 9y expired

What this patent protects

The present invention relates to pharmaceutical compositions comprising dimethyl fumarate and a pharmaceutically acceptable agent which inhibits the enzyme catalyzed degradation of dimethyl fumarate (dimethyl fumarate).

USPTO Abstract

The present invention relates to pharmaceutical compositions comprising dimethyl fumarate and a pharmaceutically acceptable agent which inhibits the enzyme catalyzed degradation of dimethyl fumarate (dimethyl fumarate).

Drugs covered by this patent

Patent Metadata

Patent number
CA2987895A1
Jurisdiction
CA
Classification
Expires
2016-12-08
Drug substance claim
No
Drug product claim
No
Assignee
Sun Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.